We are very pleased to inform you that the 8th edition of MATWIN’s international board has awarded PDC*line Pharma with the prize of most promising project in the “start-up” category.
This prize...
Three Belgian investment funds and several specialized international business angels have participated in this round, which will allow the company’s cancer immunotherapy technology to reach the...
PDC*line Pharma will attend BIO-Europe in Cologne (Germany)
November 7–9, 2016
Cologne, Germany
Let’s meet there !
PDC*line Pharma presents at the Sachs 16th Annual Biotech in Europe forum
PDC*line Pharma receives Advanced-Therapy Medicinal Product (ATMP) classification from the European Medicines Agency (EMA) for its new class of therapeutic cancer vaccines (PDC*vac)
June 15th 2015 –...
From right to left: Isabelle Tabah-Fisch (CMO), Laurent Levy (CEO) and Joel Plumas...
PDC*line Pharma received €500 k in grants and won 3 awards in 2014: the Worldwide Innovation Challenge 2030, the i-Lab French competition, and the French plan “medical biotechs”.
PDC*line Pharma was selected for the Medical Biotechnology industrial plan.
Article
A reception has taken place at the Elysee Palace for the 110 award recipients of the Worldwide Innovation Challenge 2030.
Article
PDC*line pharma has been declared as a national winner of the 2014 edition of the French competition for creation of innovative companies, in the “creation – development” category.
